Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Queensland Health
Cantor Fitzgerald
Cipla
Chinese Patent Office
Daiichi Sankyo
Baxter
Colorcon
Julphar

Generated: August 20, 2018

DrugPatentWatch Database Preview

Accord Hlthcare Company Profile

« Back to Dashboard

What is the competitive landscape for ACCORD HLTHCARE, and what generic and branded alternatives to ACCORD HLTHCARE drugs are available?

ACCORD HLTHCARE has ninety-seven approved drugs.

There are seven tentative approvals on ACCORD HLTHCARE drugs.

Summary for Accord Hlthcare
US Patents:0
Tradenames:86
Ingredients:83
NDAs:97

Drugs and US Patents for Accord Hlthcare

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare AZACITIDINE azacitidine POWDER;INTRAVENOUS, SUBCUTANEOUS 207475-001 Jul 2, 2018 AP RX No No ➤ Sign Up ➤ Sign Up
Accord Hlthcare AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride TABLET;ORAL 202446-003 Jun 4, 2014 AB RX No No ➤ Sign Up ➤ Sign Up
Accord Hlthcare NORETHINDRONE norethindrone TABLET;ORAL-28 206807-001 Dec 13, 2016 AB1 RX No No ➤ Sign Up ➤ Sign Up
Accord Hlthcare ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET;ORAL 204022-002 Feb 28, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Accord Hlthcare ARIPIPRAZOLE aripiprazole TABLET;ORAL 206251-002 Dec 7, 2016 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
US Department of Justice
Healthtrust
Dow
Citi
Moodys
McKinsey
Boehringer Ingelheim
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.